United Therapeutics Corp.
Research Triangle Park, NC, United States
3
Total Recalls
0
Class I Recalls
0
Ongoing Recalls
Recalls by United Therapeutics Corp.
FDA Drug
Class III
Terminated
Tyvaso Inhalation System Patient a) Starter Kit with TYVASO (treprostinil) Inhalation Solution. Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) (NDC 66302-206-01) b) TD-300/A Replacement Device Kit Material
August 14, 2018
United Therapeutics Corp.
2801 devices units
FDA Drug
Class II
Terminated
TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) Tyvaso Inhalation System Starter Kit Model# TD-100/A, Rx Only, Manufactured by United Therapeutics Corporation Resear
September 11, 2017
United Therapeutics Corp.
12 devices units
FDA Drug
Class II
Terminated
Tyvaso (treprostinil) Inhalation Solution, Treprostinil 1.74 mg/2.9 mL, Four 2.9 mL Ampules, For Oral Inhalation Use Only, Manufactured for United Therapeutics Corporation, Triangle Park, NC 27709
March 28, 2014
United Therapeutics Corp.
188 Units units